University of Chicago

Running trials

• Not yet recruiting

  Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium: Study 2

  NCT07875790· Washington University School of Medicine· Source

• Not yet recruiting

  Mobile Health Management of Hypertension

  NCT05856955· University of Chicago· Source

• Recruiting

  Breakthrough - T1DM and Chronic Kidney Disease

  NCT07592000· Phase 1/2· University of Chicago· Source

• Not yet recruiting

  Building Rapid Inpatient Delivery of ART to Generate Engagement in HIV Care

  NCT07847567· University of Chicago· Source

• Not yet recruiting

  A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs

  NCT07409350· NYU Langone Health· Source

• Not yet recruiting

  COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

  NCT07281027· Phase 3· Yale University· Source

• Not yet recruiting

  Collagenase Biobank Study

  NCT07211230· University of Chicago· Source

• Recruiting

  Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1

  NCT07853807· Washington University School of Medicine· Source

• Recruiting

  CommunityRx-Dementia + Peer Navigation (CRxDpeer)

  NCT07346183· University of Chicago· Source

• Not yet recruiting

  Signatera Assessment in Early-Stage Endometrial Cancer

  NCT07339384· Natera, Inc.· Source

• Recruiting

  PMOS in OSA Pilot Study

  NCT07871149· University of Chicago· Source

• Recruiting

  A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

  NCT07768189· Phase 3· Corbus Pharmaceuticals Inc.· Source

• Not yet recruiting

  Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

  NCT07520110· Phase 3· University of Massachusetts, Worcester· Source

• Not yet recruiting

  Effects of Stimulant Medications in PTSD

  NCT07664631· Phase 1· University of Chicago· Source

• Recruiting

  WATER IV PCa (AS Sub-study)

  NCT07650448· PROCEPT BioRobotics· Source

• Recruiting

  A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  NCT07623200· Phase 3· Incyte Corporation· Source

• Not yet recruiting

  NeuroRise: Intrathecal CE-1 Treatment for Traumatic SCI

  NCT07739043· Early phase 1· Cell Therapy LLC· Source

• Not yet recruiting

  Virtual Group Therapy for IBD Patients With Anxiety and Depression

  NCT07796568· University of Chicago· Source

• Recruiting

  A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

  NCT07328581· Phase 2· iCell Gene Therapeutics· Source

• Not yet recruiting

  Biasing Food Value Construction

  NCT07692945· University of Chicago· Source

• Recruiting

  Outpatient Visits Versus Telehealth for Postoperative Care After Minimally Invasive Gynecologic Surgery

  NCT07420114· University of Chicago· Source

• Recruiting

  BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIV

  NCT07502365· University of Chicago· Source

• Recruiting

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

  NCT07659782· Phase 2· Verastem, Inc.· Source

• Recruiting

  PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis

  NCT07232069· Phase 3· Duke University· Source

• Recruiting

  Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites

  NCT06837220· University of Chicago· Source

• Recruiting

  GBPDC: Gut-Brain in PD Consortium Master Protocol

  NCT07567794· Duke University· Source

• Recruiting

  A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

  NCT07644559· Phase 2· Verastem, Inc.· Source

• Recruiting

  A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment

  NCT07179315· Phase 2· University of Chicago· Source

• Not yet recruiting

  VR Therapies for IBD

  NCT07590518· Brennan Spiegel· Source

• Not yet recruiting

  Aripiprazole in Body Focused Repetitive Behaviors

  NCT05545891· Phase 2· University of Chicago· Source

• Recruiting

  Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

  NCT07278479· Phase 1/2· Molecular Partners AG· Source

• Recruiting

  AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  NCT07571005· Phase 3· Novo Nordisk A/S· Source

• Enrolling by invitation

  EEG Dynamics in Lennox-Gastaut Syndrome Patients Undergoing Fenfluramine Treatment

  NCT07555171· University of Chicago· Source

• Recruiting

  Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

  NCT07103746· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Recruiting

  Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well

  NCT07115940· Amrou Sarraj· Source

• Recruiting

  AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

  NCT07454642· Phase 1· Avacta Life Sciences Ltd· Source

• Recruiting

  A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients

  NCT07549321· Phase 2/3· Renaissance Pharma Ltd.· Source

• Recruiting

  Achieving Routine Intervention and Screening for Emotional Health

  NCT06887049· University of Chicago· Source

• Recruiting

  A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  NCT07188558· Phase 3· Lyell Immunopharma, Inc.· Source

• Recruiting

  Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

  NCT07265947· Phase 2· Tyra Biosciences, Inc· Source

• Recruiting

  Self-sampling to Optimize Anal Lesion Outcomes

  NCT07192055· Medical College of Wisconsin· Source

• Recruiting

  STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission

  NCT06693310· University of Chicago· Source

• Recruiting

  Type 1 Diabetes and Obstructive Sleep Apnea

  NCT06915831· University of Chicago· Source

• Recruiting

  Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

  NCT07069738· Boston Scientific Corporation· Source

• Recruiting

  Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer

  NCT07065630· Phase 2· University of Chicago· Source

• Recruiting

  A Study of CTD402 in T-ALL/LBL Patients

  NCT07070219· Phase 1/2· Imviva Bio· Source

• Recruiting

  Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  NCT04107077· Phase 2· University of Chicago· Source

• Recruiting

  Blinatumomab Consolidation in Real World

  NCT07117136· Medical College of Wisconsin· Source

• Recruiting

  Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

  NCT06188741· Phase 2· University of Alabama at Birmingham· Source

• Active, not recruiting

  A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

  NCT07076199· Phase 3· Novo Nordisk A/S· Source

Showing 50 of 292.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer16 recruiting
• Childhood cancers11 recruiting
• Heart failure11 recruiting
• Colorectal cancer9 recruiting
• Head and neck cancer8 recruiting
• Gastric and oesophageal cancer7 recruiting
• Prostate cancer7 recruiting
• Stroke7 recruiting
• HIV6 recruiting
• Ovarian cancer6 recruiting
• Acute lymphoblastic leukaemia5 recruiting
• Acute myeloid leukaemia5 recruiting
• Bladder cancer5 recruiting
• COPD5 recruiting
• Epilepsy5 recruiting
• High blood pressure5 recruiting
• Pancreatic cancer5 recruiting
• Peripheral artery disease5 recruiting
• Alzheimer disease4 recruiting
• Cervical cancer4 recruiting
• Coronary artery disease4 recruiting
• Crohn's disease4 recruiting
• Myeloproliferative neoplasms4 recruiting
• Obstructive sleep apnoea4 recruiting
• Atrial fibrillation3 recruiting
• Brain metastases3 recruiting
• Chronic myeloid leukaemia3 recruiting
• Endometrial cancer3 recruiting
• Idiopathic pulmonary fibrosis3 recruiting
• Liver and biliary tract cancer3 recruiting
• Lupus (SLE)3 recruiting
• Metastatic breast cancer3 recruiting
• Multiple myeloma3 recruiting
• Parkinson disease3 recruiting
• Schizophrenia3 recruiting
• Triple-negative breast cancer3 recruiting
• Type 1 diabetes3 recruiting
• Type 2 diabetes3 recruiting
• Ulcerative colitis3 recruiting
• Aortic aneurysm2 recruiting
• Brain aneurysm2 recruiting
• Chronic lymphocytic leukaemia2 recruiting
• Diffuse large B-cell lymphoma2 recruiting
• Frontotemporal dementia2 recruiting
• Melanoma2 recruiting
• Mesothelioma2 recruiting
• Neuroendocrine tumours2 recruiting
• Neurofibromatosis type 12 recruiting
• Obesity2 recruiting
• Sarcoma2 recruiting
• Spinal cord injury2 recruiting
• Aplastic anaemia1 recruiting
• Bipolar disorder1 recruiting
• Chronic kidney disease1 recruiting
• Coeliac disease1 recruiting
• Depression1 recruiting
• Dermatomyositis and polymyositis (myositis)1 recruiting
• Endometriosis1 recruiting
• Glioblastoma1 recruiting
• Hodgkin lymphoma1 recruiting
• Hypertrophic cardiomyopathy1 recruiting
• Kidney cancer1 recruiting
• Long COVID and ME/CFS1 recruiting
• Macular degeneration1 recruiting
• Meningioma1 recruiting
• Mild cognitive impairment1 recruiting
• Multiple sclerosis1 recruiting
• Myelodysplastic syndromes1 recruiting
• Myocarditis1 recruiting
• Neuroblastoma1 recruiting
• Polycystic kidney disease1 recruiting
• Polycystic ovary syndrome1 recruiting
• Pulmonary arterial hypertension1 recruiting
• Sarcoidosis1 recruiting
• Sickle cell disease1 recruiting
• Thyroid cancer1 recruiting
• Vascular dementia1 recruiting

Closed trials

• Completed

  Inhaler Trainer Efficacy Study

  NCT06461403· Koronis Biomedical Technologies· Source

• Completed

  Mood Effects of Serotonin Agonists: Depression

  NCT07017478· Early phase 1· University of Chicago· Source

• Completed

  Digital Support for Mental Health Intervention in Patients With Inflammatory Bowel Disease

  NCT06575660· University of Chicago· Source

• Completed

  Localized Body Cooling Technology on Sleep and Metabolism in African, American With Overweight and Obesity

  NCT05849181· University of Chicago· Source

• Completed

  Sleep Extension or Regularity to Reduce Diabetes Risk

  NCT06128265· University of Chicago· Source

• Terminated

  Study of IK-595 in RAS- or RAF-altered Advanced Tumors

  NCT06270082· Phase 1· Ikena Oncology· Source

• Completed

  A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps

  NCT06164704· Phase 2· Upstream Bio Inc.· Source

• Completed

  Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder

  NCT05399498· Phase 2· University of Chicago· Source

• Completed

  A Mobile Health (mHealth) Strategy for Improving Blood Pressure Control Among Adult Hypertensive African Americans

  NCT06078540· University of Chicago· Source

• Completed

  Millipede AspiRation for Revascularization in Stroke (MARRS) Study

  NCT05714501· Perfuze· Source

• Terminated

  Study of ART0380 in Patients With Biologically Selected Solid Tumors

  NCT05798611· Phase 2· Artios Pharma Ltd· Source

• Completed

  Myositis Interstitial Lung Disease Nintedanib Trial

  NCT05799755· Phase 4· Rohit Aggarwal, MD· Source

• Completed

  A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

  NCT05841030· Janssen Research & Development, LLC· Source

• Completed

  Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2)

  NCT05262270· Phase 2· University of Texas Southwestern Medical Center· Source

• Completed

  Mitigating Post-Op RV Dysfunction After LVAD Implantation

  NCT05758194· University of Chicago· Source

• Withdrawn

  INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  NCT05359692· Phase 2· Incyte Biosciences International Sàrl· Source

• Terminated

  A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)

  NCT05600426· Phase 3· Boston Children's Hospital· Source

• Completed

  Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

  NCT05669599· Phase 2· Amgen· Source

• Terminated

  A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors

  NCT05576077· Phase 1· Turnstone Biologics, Corp.· Source

• Terminated

  GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2

  NCT05130255· Phase 1· Y-mAbs Therapeutics· Source

• Completed

  A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma

  NCT05364424· Phase 1· Hoffmann-La Roche· Source

• Completed

  A Study of RGLS8429 in Patients With Autosomal Dominant Polycystic Kidney Disease

  NCT05521191· Phase 1· Regulus Therapeutics Inc.· Source

• Withdrawn

  Safety, Tolerability, and Efficacy of Immunomodulation With AT-1501 in Combination With Transplanted Islet Cells in Adults With Brittle T1D

  NCT05480657· Phase 1/2· Eledon Pharmaceuticals· Source

• Terminated

  Sacral Fracture Fusion/Fixation for Rapid Rehabilitation

  NCT05426356· SI-BONE, Inc.· Source

• Completed

  HF Patients With LVADs Being Treated With SGLT2i

  NCT05278962· Phase 4· University of Chicago· Source

• Terminated

  A Phase 1/2 Study to Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC Oncogene

  NCT05497453· Phase 1/2· Omega Therapeutics· Source

• Completed

  Novel Desensitization Kidney Transplantation

  NCT05345717· Phase 1/2· University of Chicago· Source

• Completed

  Epidiolex in Obsessive Compulsive Disorder and Related Disorders

  NCT04978428· Phase 2· University of Chicago· Source

• Terminated

  A Study to Investigate LYL797 in Adults With Solid Tumors

  NCT05274451· Phase 1· Lyell Immunopharma, Inc.· Source

• Terminated

  Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML

  NCT05275439· Phase 1· Shattuck Labs, Inc.· Source

• Completed

  Studying Heart Ablation After Left Atrial Closure in High-Bleeding-Risk Atrial Fibrillation Patients

  NCT07580937· University of Chicago· Source

• Completed

  The Reducing REVISITS Study: A Cluster RCT

  NCT05568043· University of Chicago· Source

• Completed

  AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM

  NCT06378632· Cordio Medical· Source

• Terminated

  A Phase II Trial of Poly-ICLC for Low-Grade Gliomas

  NCT04544007· Phase 2· University of Alabama at Birmingham· Source

• Terminated

  Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors

  NCT05228015· Phase 1· Ikena Oncology· Source

• Completed

  A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress Disorder

  NCT05103657· Phase 2· Boehringer Ingelheim· Source

• Withdrawn

  Nitrous Oxide as Treatment for Fibromyalgia

  NCT05357066· Phase 2· University of Chicago· Source

• Completed

  A Hybrid Type II Trial of the Optimizing Resilience and Coping With HIV Through Internet Delivery in Ryan White Clinics in Chicago

  NCT05123144· Northwestern University· Source

• Completed

  ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo

  NCT05070260· Phase 2/3· Acticor Biotech· Source

• Completed

  A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of Cancers

  NCT04879849· Phase 1· Takeda· Source

• Completed

  Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide

  NCT04335682· Phase 2· Alliance Foundation Trials, LLC.· Source

• Completed

  A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

  NCT04740671· Phase 3· Shanghai Henlius Biotech· Source

• Completed

  A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer

  NCT04702737· Phase 1· Amgen· Source

• Terminated

  Prescribed Sternal Precautions vs. Self-Guided Restrictive Care (PEEERC)

  NCT05206929· University of Chicago· Source

• Completed

  Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)

  NCT04880434· Phase 2· Kite, A Gilead Company· Source

• Completed

  Technology-Supported Treatment of Sleep Apnea in Prediabetes

  NCT04225507· University of Chicago· Source

• Completed

  Conduction System Pacing International Registry (CONSPIRE)

  NCT04831125· University of Chicago· Source

• Terminated

  Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

  NCT04827563· University of Chicago· Source

• Completed

  Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

  NCT04742959· Phase 1/2· TransThera Sciences (Nanjing), Inc.· Source

• Completed

  Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer

  NCT04744831· Phase 2· Daiichi Sankyo· Source

Showing 50 of 141.

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke174 works · 11 trials
• Lung cancer150 works · 39 trials
• Heart failure138 works · 19 trials
• HIV118 works · 9 trials
• Alzheimer disease108 works · 7 trials
• Prostate cancer98 works · 29 trials
• Ulcerative colitis89 works · 6 trials
• Crohn's disease70 works · 5 trials
• Asthma67 works · 5 trials
• Type 2 diabetes66 works · 8 trials
• Colorectal cancer60 works · 21 trials
• Atrial fibrillation49 works · 4 trials
• Melanoma48 works · 11 trials
• Triple-negative breast cancer47 works · 11 trials
• Ovarian cancer41 works · 14 trials
• Epilepsy41 works · 6 trials
• Acute myeloid leukaemia39 works · 18 trials
• Bladder cancer39 works · 16 trials
• Acute lymphoblastic leukaemia37 works · 12 trials
• Coronary artery disease33 works · 6 trials
• Deep vein thrombosis and pulmonary embolism33 works · 2 trials
• Kidney cancer32 works · 6 trials
• Schizophrenia31 works · 3 trials
• COPD29 works · 8 trials
• Pancreatic cancer28 works · 9 trials
• Multiple myeloma27 works · 19 trials
• Hodgkin lymphoma25 works · 4 trials
• Type 1 diabetes24 works · 11 trials
• Metastatic breast cancer24 works · 12 trials
• Amyloidosis24 works · 1 trial